Introduction
Sickle cell disease (SCD) is caused by a genetic mutation of the P-globin gene, resulting in production of sickle hemoglobin (Hb S), which has the tendency to polymerize when deoxygenated and causes red cells to become rigid and abnormally shaped "sickle cells." Sickle cells have a much shorter life span than normal red cells (7,s) . Fetal hemoglobin (Hb F) has been shown to be an effective inhibitor of Hb S polymerization (1, 6) . Hence, cells that contain Hb F (Fcells) survive longer in circulation than non-F-cells (4) . In addition, patients with higher Hb F levels usually have a milder clinical course (16J9). Current strategies for treatment of patients with SCD focus on raising Hb F level as a means of improving the clinical course. Both hydroxyurea (HU) (15, 20) and butyrate (5, 14) are presently being tested for this purpose. However, even among patients with similar Hb F levels there is a wide variation of clinical complications (17) . In evaluating the impact of a particular patient's ' Supported by NIH grants HL 44640 (KH), Comprehensive Sickle Cell Center Grant HL 38632 (KOEKH), and by the Ethel Brown Foerderer Fund for Excellence at The Children's Hospital of Philadelphia (KH).
Correspondence to: Kazumi Horiuchi, PhD. Children's Hospital of Philadelphia, Abramson Bldg., Rm. 310D. 34th Street and Civic Center Blvd., Philadelphia, PA 19104. our two-stage staining method, we compared our results with those obtained by traditional methods. There was significant correlation of our method with the conventional immunofluorescence staining method for F-cells (? = 0.99; slope = 0.99) and with the accepted brillant cresyl blue method for reticulocytes (? = 0.97; slope = O.%). Heretofore, the ability to determine F-reticulocyte levels has been limited to a s m a l l number of laboratories possessing special equipment and techniques. The method presented here should be of great interest to many basic science and clinical investigators involved in studies evaluating synthesis of Hb F. (J Histochem Cytochem 44:393-397, 1996) KEY WORDS: Hemoglobin F F-cells; Sickle cell disease; Image analysis; Acridine orange; Reticulocytes; Immunofluorescence.
Hb F level, three separate variables are considered: the rate of Fcell production, the amount of Hb F/F-cell, and the enhanced survival of F-cells compared to non-F-cells. A study by Rodgers et al. (18) of patients treated with HU showed that an increase in Fcell production was the main factor accounting for the Hb F elevation in these patients. The other two variables, augmentation of Hb F/F-cell and the preferential survival of Fcells, make smaller contributions. Red blood cell production can be monitored through the relative number of young cells, or reticulocytes. Knowledge of the percentage of reticulocytes that contain Hb F (Freticulocytes) would therefore be the best indicator of the rate of F-cell production. Current methods for determining Freticulocyte levels have not been widely applied because of their complexity. It would be useful to many investigators to have a simple method of measuring F-reticulocytes that can be used to monitor the response of patients on therapy with drugs such as HU and butyrate. Furthermore, the applicability of this method to in vitro cell culture studies would make it useful for the early stages of testing these types of drugs.
We have attempted to develop a reliable technique for identification of F-reticulocytes. The method presented here is relatively uncomplicated, utilizing common protocols, and should enable many laboratories to make a successful estimation of F-reticulocyte percentages. Using blood from SS patients, we identified reticulocytes with acridine orange and then, after removal of the reticulo-OSTERHOUT, OHENEFREMPONG. HORnrCHl cyte fluorescence, we stained for F-cells by an immunofluorescence method. We were then able to determine which cells in a particular group were reticulocytes, F-cells, or F-reticulocytes.
Materials and Methods
Blood Collection. After obtaining informed consent, blood was withdrawn from SS patients into heparinized tubes. Aliquots of the red cells were hemolyzed and the Hb F level in the hemolysate was measured by ion-exchange column chromatography (9,ll) .
Reticulocyte Staining and Analysis. Red cells were washed three times with PBS (9 g NaCllliter, 10 mM phosphate buffer) and, after centrifugation and removal of supernatant, fetal bovine serum (FBS Sigma, Chicago, IL) and an acridine orange solution (0.1% acridine orange wlv, 2 % bovine serum albumin, 20 mM phosphate buffer, 300 mOsmlkg H20) were added in a 1:1:1 ratio. The cells were then incubated in this mixture for 10 min at room temperature (RT). After incubation, the blood was again washed three times with PBS and FBS was added in a 2:1 ratio. We prepared monolayer smears of these stained red cells using a DiffSpin (StatSpin Technologies; Norwood, MA) slide maker. These smears were allowed to dry and could then be covered and stored for future analysis for at least 2 weeks with no reduction in staining quality.
Under fluorescence microscopy, reticulum within reticulocytes appears orange, whereas erythrocytes do not contain this orange staining, as shown in Figure 1A . This image of reticulocyte fluorescence shows that for cells with a modest amount of residual reticulum, individual grains areevident, whereas fluorescence from individual grains in cells with a higher concentration is occluded because of the high intensity of the total fluorescence. Reticulocytes are clearly distinguishable from erythrocytes. The smears were marked using a diamond pencil to provide a reference point from which to begin taking images. This enabled us to return to the same area after subsequent staining of Fcells. The stage coordinates of the microscope were also recorded for additional verification of the area. Fluorescence images and images of all cells in the same fields were obtained and saved using an SIT (siliconintensified tube) camera and an imaging system (ARGUS 50; Hamamatsu Photonic System, Bridgewater, NJ). Images of all red blood cells ( Figure   1B ) were acquired via a bandpass filter (415 * 15 nm; Omega Optical, Brattleboro, VT) that is specific to hemoglobin absorption. Sufficient images were taken to provide at least 200 reticulocytes.
Extraction of Reticulocyte Staining. Any residual reticulocyte staining that remains after F-cell staining would conflict with analysis of F-cells be--* a cause faded acridine orange fluorescence appears green, which is at a similar wavelength as fluorescence from Fcells stained with fluorescein isothiocyanate (FIX). Therefore, before staining for F-cells it was necessary to remove the acridine orange from the cells. To do this, smears were first washed for 10 min in a fixative solution consisting of acetone, methanol, and ethanol in a ratio of 3:l:l. Then 20 ~1 of a ribonuclease solution (50 Fglml ribonuclease A; Amenham Life Sciences, Poole. UK) was applied to the selected area of each smear and they were incubated for 10 min at RT. The smears were then washed in PBS for 10 min. After this procedure the remaining fluorescence from acridine orange was negligible. This procedure adequately eliminated the fluorescence to the extent that it would not interfere with Fcell analysis.
&cell Staining by an Immunofluo"x Method. Fcells were stained in accordance with the immunofluorescence method reported by Papayannopoulou et al. (13) . with some modification (9,ll) . Smears cleared of acridine orange as explained above were washed in PBS, then in distilled water, for 5 min each. Using the mark made on the slide as a reference, monoclonal antibody for y-globin (0.2 mglml, murine anti-human y-globin; Immuno-nr, Augusta, GA) was applied to the same area for which images of reticulocytes were obtained, and the smears were incubated in a humidified chamber for 1 hr at 37°C. The smears were then washed again in PBS and in distilled water for 10 min each. A secondary antibody (0.7 mglml. goat anti-mouse IgG; Cappel Research Products, Durham, NC) labeled with a fluorescence probe, FIK, was applied to the same area, and the smears were incubated for 45 min at 37'C and washed in PBS and in distilled water for 10 min each. After drying an anti-fading gel (8.7 mglml gelatin, 13% glycerin. 17.4 mglml phenol, 50 mglml DABCO, 5 mglml NaN3.20 mM phosphate buffer) was applied to the stained area of the smears and they were covered with microscope coverslips to provide a stable fluorescence intensity for analysis (10) . Under fluorescence microscopy, Fcells appear green and non-Fcells are invisible ( Figure IC) .
Determination of F-reticulocytes. By referring to the images of all cells taken after reticulocyte staining and the mark on the slide. it was possible to return to the exact same area and obtain fluorescence images of Fcells. Using fluorescence images of reticulocytes and of Fcells, and the image of all cells for a particular field, we were then able to determine which cells were reticulocytes, F-cells, and F-reticulocytes. The criteria used to define reticulocytes are similar to those used in the traditional brilliant cresyl blue method. Any cell in which at least two grains of reticulum were visible by fluorescence signals was designated as a reticulqe, i.e., cells containing only one grain were eliminated in this estimation. Typical images obtained using this procedure are shown in Figure 1 confirm that the fluorescence emanating from both reticulocytes and F cells obtained with our method allow a clear determination of these cells, and subsequently of F-reticulocytes.
Validation of the Two-stage Staining Method. We stained simultaneously specimens from the same blood for F-cells using the traditional immunofluorescence staining method as previously reported (9) . We also determined reticulocyte percentages for the same samples using the traditional method, which utilizes brilliant cresyl blue (12) . Comparisons were made between data from our current two-stage method and the established methods using a linear regression method. In addition, to assess the interobserver and intraobserver variability inherent in this analysis, four of these samples with Hb F levels spanning the possible range were selected for multiple analyses of F-cell and reticulocyte percentages. Because these samples were selected according to Hb F level and did not span the range of reticulocyte levels, an additional fifth sample with a high percentage of reticulocytes was also analyzed by multiple observers to estimate reticulocyte percentages. These samples were analyzed three times in a blinded fashion by the primary observer, as well as one time each by four additional observers, three of whom were inexperienced. The inexperienced observers were provided with a basic explanation of the definition of these cells before beginning their analysis.
Results
To assess the validity of our new two-stage staining method, we compared the percentages of reticulocytes and F-cells obtained by applying this method with those obtained through application of the traditional methods for determining each of these parameters independently. For this purpose, 15 SS subjects with various Hb F levels were examined. There is a good correlation between the values estimated from our method with those from the traditional method (s = 0.97; slope = 0.96). The mean and SD of reticulocyte percentages estimated from multiple analyses of the selected samples, designated by the closed symbols, are also presented in this figure. One sample, whose mean reticulocyte percentage is 0.9%, has an SD of 0.8%, which is too small to appear in the figure. Furthermore, despite the inexperienced nature of some of the observers, the SD for all of these multiple analyses is less than 2%. The relationship between the F-cell percentages obtained using our two-stage staining method with removal of acridine orange and the customary method of F-cell identification by immunofluorescence staining was also very good, as shown in Figure 3 (r2 = 0.99; slope = 0.99). This figure also includes the mean and SD of multiple analyses of the selected samples. The sample with a mean Fcell percentage of 7.0% has a small SD of 0.5%, which likewise does not appear. Once again, there is very little variation between observers, including novices; SDs are all 43 %. Accordingly, Freticulocyte percentages estimated from these analyses by multiple observers also showed low variability.
We examined the relationships between each type of cell identified using our two-stage staining method, reticulocytes, F-cells, and F-reticulocytes, with hemolysate Hb F level, as well as the relationship between F-erythrocytes and Freticulocytes for each of these patients. These are shown in Figure 4 . The relationship between F-cell percentage and Hb F level ( Figure 4A) is consistent with earlier reports (2, 9) . As Hb F level increases, the percentage of F-cells generally increases. Likewise, the distribution of reticulocyte percentages at various Hb F levels ( Figure 4B ) agrees with what is empirically known. There is much variation among reticulocyte percentages at low Hb F levels, and as Hb F levels increase reticulocyte F level (a,b,c, F-erythrocytes (d) . Blood from 15 SCD patients was used for these analyses.
respectively) and the relationship between F-reticulocytes and
percentages tend to decrease. Our analysis of F-reticulocytes showed that although there is some variation, the general observable trend is that F-reticulocyte percentages increase with increasing Hb F level ( Figure 4C ). We compared our data with data provided by Dover et al. ( 4 ) and found that they were comparable. We also examined our data for the relationship between F-reticulocyte percentages and F-erythrocyte percentages ( Figure 4D ) with those of Dover et al. and again found much similarity. Again, although there is some deviation, the general tendency is that F-reticulocyte percentages increase as F-erythrocyte percentages increase.
Discussion
In 1978, Dover et al. (3) reported a method for detecting F-reticulocytes by a modification of the single-cell radial immunodiffusion method. F-reticulocytes were identified by coincident recognition of reticulocytes by new methylene blue and F-cells by pericellular immunoprecipitates. They then counted at least 250 reticulocytes and 1000 red blood cells and an accurate measurement of F-reticulocyte percentages was obtainable when F-cell frequency in whole blood multiplied by reticulocyte frequency was greater than or equal to 5 x IO-*. This method has proven to be very reliable and has been of great use in studies performed since its evolution. The major problem reported in connection with this method was observer bias. Perseverance by the observer was believed to lead to overestimation, especially when F-cell and reticulocyte percentages were low. Because our method also utilizes visual iden-tification of reticulocytes and F-cells, the error incurred by observer bias when both reticulocyte and F-cell percentages are low should be similar. However, as we have shown here, the correlation between F-cell and reticulocyte percentages estimated using our twostage staining method with those estimated by performing separate F-cell and reticulocyte analyses is very high. Similarly, as shown in Figures 2 and 3 , although there is some variability among observers, this variability is very low. In addition, the data from our method regarding levels of F-reticulocytes and their relationship to those of hemolysate Hb F and F-erythrocytes are consistent with the data reported by Dover et al. (4) .
In 1980, Papayannopoulou et al. (13) reported a different fluorescence method for identification of F-reticulocytes. Using whole blood with new methylene blue, they simultaneously stained F-cells and reticulocytes using an anti-Hb F antibody conjugated to F I X and acridine orange, respectively. They asserted that by these means the precipitated reticulum of reticulocytes would appear orange, whereas anti-Hb F-FITC would label Hb F green, and that both would be visible under fluorescence microscopy. However, our experience with that method has shown us that simultaneous staining of reticulocytes and F-cells is extremely difficult to obtain. This led us to develop the method we describe here, which uses some of the techniques developed by Papayannopoulou et al. but enables us to determine reticulocytes and F-cells separately for a group of cells and to use these analyses to determine F-reticulocytes.
In addition, because of the clarity of fluorescence and the manner of observation and tabulation, our method of determining F-cells and reticulocytes may be superior to other methods that rely upon visual estimation. Other methods of visual estimation, such as the brilliant cresyl blue method, are based solely on counting cells viewed through a microscope. Our experience with the traditional method utilizing brilliant cresyl blue to identify reticulocytes has shown that this method is quite difficult, especially when cells contain dim or few grains of reticulum. This difficulty produces significant interobserver variability. The observer variability may be reduced in our method because of brighter and clearer fluorescence signals from acridine orange and the fashion in which the sample is viewed and data for each cell recorded. The observer views captured images of cells on a monitor with a high magnification and records on a printed image of the field which cells are positive and negative. Therefore, error caused by ambiguous classifications and miscounting is reduced.
Another factor that may be a benefit of our method is its practicality. Although the initial cost of setting up the laboratory with the required equipment may be substantial, future costs are negligible. The bare minimum required to perform F-reticulocyte analysis according to our method is simply a microscope connected to a camera with which to photograph the stained areas. Although we have used an imaging system to acquire and save images, the same results can also be obtained with a microscope connected to a Macintosh computer using the public domain NIH Image program (written by Wayne Rasband at the US National Institutes of Health and available from the Internet by anonymous ftp from zippy.nimh.nih.gov or on floppy disk from NTIS, 5285 Port Royal Rd., Springfield, VA 22161, part number PB93-504868) and an image grabber board. When these points are considered in addition to the fact that the cost of supplies and the manpower required for each analysis are also reasonable, this method becomes very attractive for widespread use.
The method we have reported here is relatively simple and should enable others to make similar determinations of F-reticulocytes with considerable accuracy. Because F-reticulocytes are the best indicator of the level of F-cell production, this method should be extremely beneficial to future studies that explore approaches to increasing Hb F level as a means of ameliorating the complications of SCD and p-thalassemia. It will therefore be especially valuable in evaluating the response to drugs and genetic manipulations aimed at increasing the levels of H b F. In addition, using this method together with the method we have recently developed for determining Hb F levels in individual F-cells (IO) should make it possible to determine Hb F levels in individual F-reticulocytes and, subsequently, the distribution of Hb F among F-reticulocytes. This may provide additional information in the assessment of Hb F production at the individual cell level. Studies to determine the distribution of Hb F among F-reticulocytes in patients during different stages of HU and butyrate therapy are planned.
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